US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Indaptus Therapeutics, Inc.

0.3248

-0.0143-4.22%

Post-market: 0.3120-0.0128-3.94%19:16 EDT

Volume:142.97K

Turnover:46.34K

Market Cap:5.21M

PE:-0.22

High:0.3429

Open:0.3289

Low:0.3100

Close:0.3391

Loading ...

Overview Company News Filings

Indaptus Therapeutics Expands Patent Portfolio in China, Japan, and Israel, Strengthening its Intellectual Property for Infectious Disease and Cancer Treatments

Indaptus Therapeutics Enters Standby Equity Purchase Deal With YA II PN

MT Newswires Live

BRIEF-Indaptus Therapeutics Enters Equity Purchase Agreement With Ya II Pn

Indaptus Therapeutics Inc - Can Sell up to $20 Million of Stock to Yorkville

THOMSON REUTERS

Indaptus Therapeutics Inc - Enters Equity Purchase Agreement With Ya Ii Pn

THOMSON REUTERS

BRIEF-Indaptus Therapeutics Files Prospectus Relating To Proposed Resale By Selling Stockholders Of Up To 4.4 Million Shares

Indaptus Therapeutics Inc: Files Prospectus Relating to Proposed Resale by Selling Stockholders of up to 4.4 Mln Shares

THOMSON REUTERS

Indaptus Therapeutics Says Health Canada Approves Start of Lead Asset Decoy20 Trial

MT Newswires Live

Indaptus Therapeutics Receives Approval From Health Canada to Expand Clinical Trial of Decoy20

THOMSON REUTERS

Indaptus Therapeutics Receives Approval from Health Canada to Expand Clinical Trial of Decoy20

BRIEF-Indaptus Therapeutics Inc - Not In Compliance With Nasdaq Minimum Bid Price Requirements

Indaptus Therapeutics Inc - Not in Compliance With Nasdaq Minimum Bid Price Requirements

THOMSON REUTERS

Indaptus Therapeutics, Inc. Announces $2.25 Million Private Placement Priced at-the-Market Under Nasdaq Rules

THOMSON REUTERS

Indaptus Therapeutics- Combined Effective Purchase Price for Each Share & Warrants Is $1.065

THOMSON REUTERS

Indaptus Therapeutics Inc - Gross Proceeds From Offering Expected to Be $2.25 Million

THOMSON REUTERS

Indaptus Therapeutics, Inc. Announces $2.25 Million Private Placement Priced At-The-Market Under Nasdaq Rules

BRIEF-Indaptus Therapeutics Provides Year-End Review And Outlook For 2025

Indaptus Therapeutics Provides Year-End Review and Outlook for 2025

THOMSON REUTERS

Indaptus Therapeutics Provides Year-End Review and Outlook for 2025

Indaptus Therapeutics Plans 1.94 Million Secondary Share Offering

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/INDP/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"INDP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INDP\",,,,,undefined,":{"symbol":"INDP","market":"US","secType":"STK","nameCN":"Indaptus Therapeutics, Inc.","latestPrice":0.3248,"timestamp":1749844800000,"preClose":0.3391,"halted":0,"volume":142973,"hourTrading":{"tag":"盘后","latestPrice":0.312,"preClose":0.3248,"latestTime":"19:16 EDT","volume":742,"amount":234.7534,"timestamp":1749856571335},"delay":0,"floatShares":9783100,"shares":16034444,"eps":-1.462092,"marketStatus":"Market Closed","change":-0.0143,"latestTime":"06-13 16:00:00 EDT","open":0.3289,"high":0.3429,"low":0.31,"amount":46335.70208884001,"amplitude":0.097022,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.462092,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1750060800000},"marketStatusCode":7,"adr":0,"listingDate":1438660800000,"exchange":"NASDAQ","adjPreClose":0.3391,"preHourTrading":{"tag":"盘前","latestPrice":0.3298,"preClose":0.3391,"latestTime":"08:46 EDT","volume":7818,"amount":2581.91615586,"timestamp":1749818771516},"postHourTrading":{"tag":"盘后","latestPrice":0.312,"preClose":0.3248,"latestTime":"19:16 EDT","volume":742,"amount":234.7534,"timestamp":1749856571335},"volumeRatio":0.14897285182147804},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INDP\",,,,,undefined,":{"symbol":"INDP","floatShares":9783100,"roa":"-122.21%","roe":"-259.00%","lyrEps":-1.605653,"volumeRatio":0.14897285182147804,"shares":16034444,"dividePrice":0,"high":0.3429,"amplitude":0.097022,"preClose":0.3391,"low":0.31,"week52Low":0.31,"pbRate":"1.86","week52High":2.7,"institutionHeld":0,"latestPrice":0.3248,"eps":-1.462092,"divideRate":0,"volume":142973,"delay":0,"ttmEps":-1.462092,"open":0.3289,"prevYearClose":0.8421,"prevWeekClose":0.3433,"prevMonthClose":0.338,"prevQuarterClose":0.5499,"fiveDayClose":0.3433,"twentyDayClose":0.42,"sixtyDayClose":0.7705},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"INDP\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2516675441","title":"Indaptus Therapeutics Expands Patent Portfolio in China, Japan, and Israel, Strengthening its Intellectual Property for Infectious Disease and Cancer Treatments","url":"https://stock-news.laohu8.com/highlight/detail?id=2516675441","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516675441?lang=en_us&edition=fundamental","pubTime":"2025-03-04 21:00","pubTimestamp":1741093200,"startTime":"0","endTime":"0","summary":"NEW YORK, March 04, 2025  -- Indaptus Therapeutics, Inc. , a clinical-stage biotechnology company dedicated to developing novel treatments for cancer and viral infections, announced today that it has secured new patent approvals in China, Japan and Israel for its Decoy platform. These patents cover the use of Decoy bacteria compositions for preventing or treating Hepatitis B virus  and human immunodeficiency virus  – two diseases that continue to pose major global health challenges. The patents also extend to combination therapies with a variety of both approved and investigational treatments.Dr. Michael Newman, Founder and Chief Scientific Officer of Indaptus, commented, “The allowance of these patents in key international markets highlights the potential of our Decoy platform in the fight against chronic infectious diseases. With millions of people affected by HBV and HIV worldwide, expanding our intellectual property reinforces the novelty and therapeutic promise of our approach.”","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/indaptus-therapeutics-expands-patent-portfolio-130000815.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4606","LENZ","BK4139","INDP","NLR"],"gpt_icon":0},{"id":"2511406300","title":"Indaptus Therapeutics Enters Standby Equity Purchase Deal With YA II PN","url":"https://stock-news.laohu8.com/highlight/detail?id=2511406300","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511406300?lang=en_us&edition=fundamental","pubTime":"2025-02-13 01:29","pubTimestamp":1739381378,"startTime":"0","endTime":"0","summary":"Indaptus Therapeutics  said Wednesday it has entered a standby equity purchase agreement with YA II PN, or Yorkville.Under the deal, the company can sell up to $20 million worth of its common stock to Yorkville over the next 36 months but is not obligated to do so. The company also issued 305,960 common shares to Yorkville as a commitment for Yorkville to purchase these shares, according to a filing.Indaptus said it cannot sell more than about 2.8 million shares without shareholder approval or unless the average price per share is at least $0.82. Additionally, Yorkville can't own more than 9.99% of the company's voting shares.Before any shares can be sold, the company is required to file a registration statement with the US Securities and Exchange Commission for the shares involved in this agreement.The agreement replaces the previous purchase agreement the company had with Lincoln Park Capital Fund, which was terminated on Wednesday, it said.Shares of Indaptus Therapeutics fell past 2","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK4139","EQR","PN","LENZ","BK4215","BK4588","INDP"],"gpt_icon":0},{"id":"2510706613","title":"BRIEF-Indaptus Therapeutics Enters Equity Purchase Agreement With Ya II Pn","url":"https://stock-news.laohu8.com/highlight/detail?id=2510706613","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510706613?lang=en_us&edition=fundamental","pubTime":"2025-02-12 22:29","pubTimestamp":1739370563,"startTime":"0","endTime":"0","summary":"BRIEF-Indaptus Therapeutics Enters Equity Purchase Agreement With Ya II PnFeb 12  - Indaptus Therapeutics INDP.O:INDAPTUS THERAPEUTICS INC - ENTERS EQUITY PURCHASE AGREEMENT WITH YA II PNINDAPTUS THERAPEUTICS INC - CAN SELL UP TO $20 MILLION OF STOCK TO YORKVILLESource text: [ID:n0001493152-25-006052]Further company coverage: INDP.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250212:nFWN3P31RX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INDP","BK4139"],"gpt_icon":0},{"id":"2510721377","title":"Indaptus Therapeutics Inc - Can Sell up to $20 Million of Stock to Yorkville","url":"https://stock-news.laohu8.com/highlight/detail?id=2510721377","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510721377?lang=en_us&edition=fundamental","pubTime":"2025-02-12 22:23","pubTimestamp":1739370205,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250212:nFWN3P31RX:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INDP","BK4139"],"gpt_icon":0},{"id":"2510377723","title":"Indaptus Therapeutics Inc - Enters Equity Purchase Agreement With Ya Ii Pn","url":"https://stock-news.laohu8.com/highlight/detail?id=2510377723","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510377723?lang=en_us&edition=fundamental","pubTime":"2025-02-12 22:23","pubTimestamp":1739370205,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250212:nFWN3P31RX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","INDP"],"gpt_icon":0},{"id":"2509251966","title":"BRIEF-Indaptus Therapeutics Files Prospectus Relating To Proposed Resale By Selling Stockholders Of Up To 4.4 Million Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2509251966","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509251966?lang=en_us&edition=fundamental","pubTime":"2025-02-06 05:24","pubTimestamp":1738790677,"startTime":"0","endTime":"0","summary":"BRIEF-Indaptus Therapeutics Files Prospectus Relating To Proposed Resale By Selling Stockholders Of Up To 4.4 Million SharesFeb 5  - Indaptus Therapeutics Inc INDP.O:INDAPTUS THERAPEUTICS INC: FILES PROSPECTUS RELATING TO PROPOSED RESALE BY SELLING STOCKHOLDERS OF UP TO 4.4 MILLION SHARESSource text: [ID:n0001493152-25-005016]Further company coverage: INDP.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250205:nFWN3OW1AY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","INDP"],"gpt_icon":0},{"id":"2509251896","title":"Indaptus Therapeutics Inc: Files Prospectus Relating to Proposed Resale by Selling Stockholders of up to 4.4 Mln Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2509251896","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509251896?lang=en_us&edition=fundamental","pubTime":"2025-02-06 05:18","pubTimestamp":1738790299,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250205:nFWN3OW1AY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","INDP"],"gpt_icon":0},{"id":"2509533233","title":"Indaptus Therapeutics Says Health Canada Approves Start of Lead Asset Decoy20 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2509533233","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509533233?lang=en_us&edition=fundamental","pubTime":"2025-02-05 23:39","pubTimestamp":1738769972,"startTime":"0","endTime":"0","summary":"Indaptus Therapeutics  said Wednesday it received clinical trial authorization from Health Canada for its Decoy20 drug candidate.The approval allows expansion of the company's ongoing US phase 1 study, INDP-D101, in patients with locally advanced or metastatic solid tumors to Canadian sites, according to Indaptus.The company said it will enroll patients in Canada under the current protocol of weekly dosing of Decoy20. Indaptus plans to amend the Health Canada submission to include its upcoming Decoy20 and BeiGene's tislelizumab combination trial.Shares of the company were down 1.3% in recent trading.Price: 0.89, Change: -0.01, Percent Change: -1.33","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LENZ","BK4139","INDP"],"gpt_icon":0},{"id":"2509833452","title":"Indaptus Therapeutics Receives Approval From Health Canada to Expand Clinical Trial of Decoy20","url":"https://stock-news.laohu8.com/highlight/detail?id=2509833452","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509833452?lang=en_us&edition=fundamental","pubTime":"2025-02-05 21:00","pubTimestamp":1738760403,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250205:nTUA6PNP9N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INDP","BK4139"],"gpt_icon":0},{"id":"2509573283","title":"Indaptus Therapeutics Receives Approval from Health Canada to Expand Clinical Trial of Decoy20","url":"https://stock-news.laohu8.com/highlight/detail?id=2509573283","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509573283?lang=en_us&edition=fundamental","pubTime":"2025-02-05 21:00","pubTimestamp":1738760400,"startTime":"0","endTime":"0","summary":"NEW YORK, Feb. 05, 2025  -- Indaptus Therapeutics, Inc.  , a clinical-stage biotechnology company pioneering innovative cancer and viral infection treatments, today announced the Company has received Clinical Trial Authorization from Health Canada to initiate its clinical trial for its lead asset, Decoy20. This approval will allow the Company to expand its ongoing U.S. clinical trial, INDP-D101, to Canadian sites, broadening patient recruitment and enhancing its clinical research program. The trial will enroll patients in Canada under the current protocol, which involves weekly dosing of Decoy20. Indaptus also plans to submit an amendment to Health Canada to incorporate its upcoming combination trial, which pairs Decoy20 with Beigene’s PD-1 checkpoint inhibitor,tislelizumab.Jeffrey Meckler, CEO of Indaptus, commented, “We are pleased to bring Canadian investigators and patients into our clinical efforts, creating a more diverse and robust data set. Health Canada’s approval followed a c","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/indaptus-therapeutics-receives-approval-health-130000809.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4606","BK4139","LENZ","NLR","INDP"],"gpt_icon":0},{"id":"2508916365","title":"BRIEF-Indaptus Therapeutics Inc - Not In Compliance With Nasdaq Minimum Bid Price Requirements","url":"https://stock-news.laohu8.com/highlight/detail?id=2508916365","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508916365?lang=en_us&edition=fundamental","pubTime":"2025-02-01 07:27","pubTimestamp":1738366024,"startTime":"0","endTime":"0","summary":"BRIEF-Indaptus Therapeutics Inc - Not In Compliance With Nasdaq Minimum Bid Price RequirementsIndaptus Therapeutics Inc INDP.O:INDAPTUS THERAPEUTICS INC - NOT IN COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENTSSource text: [ID:n0001493152-25-004428]Further company coverage: INDP.O","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250131:nFWN3OR103:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","INDP"],"gpt_icon":0},{"id":"2508972129","title":"Indaptus Therapeutics Inc - Not in Compliance With Nasdaq Minimum Bid Price Requirements","url":"https://stock-news.laohu8.com/highlight/detail?id=2508972129","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508972129?lang=en_us&edition=fundamental","pubTime":"2025-02-01 05:16","pubTimestamp":1738358165,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250131:nFWN3OR103:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","INDP"],"gpt_icon":0},{"id":"2503730955","title":"Indaptus Therapeutics, Inc. Announces $2.25 Million Private Placement Priced at-the-Market Under Nasdaq Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2503730955","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503730955?lang=en_us&edition=fundamental","pubTime":"2025-01-13 21:00","pubTimestamp":1736773202,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250113:nTUAB5Z8JS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","INDP"],"gpt_icon":0},{"id":"2503630927","title":"Indaptus Therapeutics- Combined Effective Purchase Price for Each Share & Warrants Is $1.065","url":"https://stock-news.laohu8.com/highlight/detail?id=2503630927","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503630927?lang=en_us&edition=fundamental","pubTime":"2025-01-13 21:00","pubTimestamp":1736773202,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250113:nTUAB5Z8JS:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INDP","BK4139"],"gpt_icon":0},{"id":"2503309206","title":"Indaptus Therapeutics Inc - Gross Proceeds From Offering Expected to Be $2.25 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2503309206","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503309206?lang=en_us&edition=fundamental","pubTime":"2025-01-13 21:00","pubTimestamp":1736773202,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250113:nTUAB5Z8JS:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","INDP"],"gpt_icon":0},{"id":"2503309447","title":"Indaptus Therapeutics, Inc. Announces $2.25 Million Private Placement Priced At-The-Market Under Nasdaq Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2503309447","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503309447?lang=en_us&edition=fundamental","pubTime":"2025-01-13 21:00","pubTimestamp":1736773200,"startTime":"0","endTime":"0","summary":"NEW YORK, Jan. 13, 2025  -- Indaptus Therapeutics, Inc.  , a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection treatments, today announced that it has entered into securities purchase agreements with investors for the issuance and sale in a private placement priced at-the-market under Nasdaq rules of an aggregate of 2,109,383 of its shares of common stock and accompanying warrants to purchase up to an aggregate of 2,109,383 of its shares of common stock. The combined effective purchase price for each share of common stock and associated warrants is $1.065. The closing of the offering is expected to take place on or about January 15, 2025, subject to the satisfaction of customary closing conditions.The warrants will have an exercise price of $0.94 per share, will be immediately exercisable upon issuance and have a term of five years from the date of issuance.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/indaptus-therapeutics-inc-announces-2-130000384.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TQQQ","MNQmain","USJW.SI","INDP","LU2210149790.SGD","BK4139","NDAQ","NVIW.SI","IE00BGHQF748.EUR","QID","BK4585","USAW.SI","IE00B3QW5Z07.USD","NQmain","IE00BKPKM429.USD",".IXIC","BK4588","BK4112","SQQQ","TSYW.SI","LU2210150020.SGD","QLD","PSQ","LU2095319765.USD","IE00B64PRP62.GBP"],"gpt_icon":1},{"id":"2501721098","title":"BRIEF-Indaptus Therapeutics Provides Year-End Review And Outlook For 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2501721098","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501721098?lang=en_us&edition=fundamental","pubTime":"2025-01-08 21:06","pubTimestamp":1736341580,"startTime":"0","endTime":"0","summary":"BRIEF-Indaptus Therapeutics Provides Year-End Review And Outlook For 2025Jan 8 (Reuters) - Indaptus Therapeutics Inc INDP.O:INDAPTUS THERAPEUTICS PROVIDES YEAR-END REVIEW AND OUTLOOK FOR 2025Source text: nGNX33YsV2Further company coverage: INDP.O ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250108:nTUA40FNCH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","INDP"],"gpt_icon":0},{"id":"2501969721","title":"Indaptus Therapeutics Provides Year-End Review and Outlook for 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2501969721","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501969721?lang=en_us&edition=fundamental","pubTime":"2025-01-08 21:00","pubTimestamp":1736341200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250108:nTUA40FNCH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","INDP"],"gpt_icon":0},{"id":"2501721041","title":"Indaptus Therapeutics Provides Year-End Review and Outlook for 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2501721041","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501721041?lang=en_us&edition=fundamental","pubTime":"2025-01-08 21:00","pubTimestamp":1736341200,"startTime":"0","endTime":"0","summary":"Continued Strong Clinical Progress and Planned New Combination Trial Provide Significant Momentum for 2025. NEW YORK, Jan. 08, 2025  -- Indaptus Therapeutics, Inc.  , a clinical-stage biotechnology company pioneering innovative cancer and viral infection treatments, today highlights its accomplishments in 2024 and outlines the Company’s strategic goals for the year ahead.Advancing Decoy20 in Clinical Trials2024 was a year of meaningful progress for Indaptus’ lead clinical candidate, Decoy20, a novel immunotherapy designed to harness both innate and adaptive immune responses. Highlights from the Company’s Phase 1 clinical trial include:. Second Cohort Results : Building on the Company’s November 2023 findings, Decoy20 demonstrated a broad immune response across multiple tumor types in patients, underscoring the platform’s potential as a monotherapy.Weekly-Dose Cohort Initiation : After receiving Safety Review Committee approval, the Company dosed its first patient in the weekly-dose por","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/indaptus-therapeutics-provides-end-review-130000198.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4080","LENZ","BK4231","SITC","BK4139","INDP","NLR"],"gpt_icon":0},{"id":"2493714506","title":"Indaptus Therapeutics Plans 1.94 Million Secondary Share Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2493714506","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493714506?lang=en_us&edition=fundamental","pubTime":"2024-12-24 06:42","pubTimestamp":1734993736,"startTime":"0","endTime":"0","summary":"Indaptus Therapeutics (INDP) filed a registration statement Monday with the Securities and Exchange Commission for a proposed secondary offering of about 1.94 million shares.The company won't receive ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["INDP","BK4139","LENZ"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":40,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/INDP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-14","symbol":"INDP","fiscalQuarterEnding":"2025/03","expectedEps":-0.41,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747195200000,"reportTimeType":"pre","actualEps":-0.32},{"market":"US","date":"2025-03-13","symbol":"INDP","fiscalQuarterEnding":"2024/12","expectedEps":-0.41,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1741838400000,"reportTimeType":"pre","actualEps":-0.38},{"market":"US","date":"2024-11-12","symbol":"INDP","fiscalQuarterEnding":"2024/09","expectedEps":-0.47,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-0.32},{"market":"US","date":"2024-08-12","symbol":"INDP","fiscalQuarterEnding":"2024/06","expectedEps":-0.54,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723435200000,"reportTimeType":"pre","actualEps":-0.47},{"market":"US","date":"2024-05-08","symbol":"INDP","fiscalQuarterEnding":"2024/03","expectedEps":-0.57,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715140800000,"reportTimeType":"pre","actualEps":-0.45}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"INDP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"INDP\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1671076800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/INDP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"INDP","date":"2025-06-13","current":-0.345273,"percent":0.995767,"low":-18.4548,"twenty":-3.137917,"median":-1.167696,"eighty":-0.925982,"high":-0.323992,"avg":-2.861555,"sd":3.908478,"marketCap":5437279},"quantilePoints":[{"date":"2021-08-06","current":-14.339657,"twenty":-15.057136,"median":-14.339657,"eighty":-13.763017,"marketCap":52167542},{"date":"2021-08-13","current":-12.289012,"twenty":-14.509058,"median":-13.737837,"eighty":-13.304373,"marketCap":44707314},{"date":"2021-08-20","current":-14.469939,"twenty":-14.417826,"median":-13.53723,"eighty":-12.946988,"marketCap":49788919},{"date":"2021-08-27","current":-15.554006,"twenty":-15.10781,"median":-14.271254,"eighty":-13.304373,"marketCap":53519033},{"date":"2021-09-03","current":-13.872917,"twenty":-15.546586,"median":-14.469939,"eighty":-13.425495,"marketCap":47734653},{"date":"2021-09-10","current":-11.987582,"twenty":-15.514027,"median":-14.20285,"eighty":-12.844352,"marketCap":41247497},{"date":"2021-09-17","current":-15.836806,"twenty":-15.554006,"median":-14.271254,"eighty":-12.616027,"marketCap":54492107},{"date":"2021-09-24","current":-13.857205,"twenty":-15.550296,"median":-13.938443,"eighty":-12.791992,"marketCap":47680593},{"date":"2021-10-01","current":-12.23896,"twenty":-15.514027,"median":-13.810072,"eighty":-12.616027,"marketCap":42112451},{"date":"2021-10-08","current":-12.066138,"twenty":-15.365473,"median":-13.700094,"eighty":-12.24897,"marketCap":41517795},{"date":"2021-10-15","current":-12.254672,"twenty":-15.066962,"median":-13.437221,"eighty":-12.094418,"marketCap":42166511},{"date":"2021-10-22","current":-11.264871,"twenty":-14.828152,"median":-13.254895,"eighty":-12.003293,"marketCap":38760754},{"date":"2021-10-29","current":-17.049854,"twenty":-15.514027,"median":-13.358664,"eighty":-12.003293,"marketCap":58666025},{"date":"2021-11-05","current":-17.930922,"twenty":-15.874513,"median":-13.53723,"eighty":-12.075565,"marketCap":61697649},{"date":"2021-11-12","current":-17.835672,"twenty":-16.960623,"median":-13.755083,"eighty":-12.132124,"marketCap":61369906},{"date":"2021-11-19","current":-8.792257,"twenty":-16.81718,"median":-13.53723,"eighty":-11.880747,"marketCap":46293721},{"date":"2021-11-26","current":-9.010118,"twenty":-16.528095,"median":-13.378591,"eighty":-11.484827,"marketCap":47440822},{"date":"2021-12-03","current":-8.10755,"twenty":-16.480962,"median":-13.241828,"eighty":-11.264871,"marketCap":42688546},{"date":"2021-12-10","current":-9.554771,"twenty":-15.88394,"median":-12.993094,"eighty":-10.504024,"marketCap":50308575},{"date":"2021-12-17","current":-9.368033,"twenty":-15.836806,"median":-12.529616,"eighty":-9.554771,"marketCap":49325345},{"date":"2021-12-23","current":-9.414717,"twenty":-15.610566,"median":-12.388216,"eighty":-9.40538,"marketCap":49571152},{"date":"2021-12-31","current":-8.870065,"twenty":-15.554006,"median":-12.289012,"eighty":-9.333798,"marketCap":46703400},{"date":"2022-01-07","current":-8.745572,"twenty":-15.539165,"median":-12.246816,"eighty":-9.284001,"marketCap":46047913},{"date":"2022-01-14","current":-8.216481,"twenty":-15.449745,"median":-12.113271,"eighty":-9.035016,"marketCap":43262097},{"date":"2022-01-21","current":-7.531774,"twenty":-15.239784,"median":-11.987582,"eighty":-8.870065,"marketCap":39656922},{"date":"2022-01-28","current":-7.142736,"twenty":-14.972695,"median":-11.854038,"eighty":-8.810931,"marketCap":37608527},{"date":"2022-02-04","current":-7.469528,"twenty":-14.727601,"median":-11.484827,"eighty":-8.717562,"marketCap":39329179},{"date":"2022-02-11","current":-7.562897,"twenty":-14.624015,"median":-11.296293,"eighty":-8.428118,"marketCap":39820793},{"date":"2022-02-18","current":-7.173859,"twenty":-14.596747,"median":-11.217738,"eighty":-8.344085,"marketCap":37772399},{"date":"2022-02-25","current":-6.504714,"twenty":-14.535926,"median":-11.10776,"eighty":-8.18847,"marketCap":34249160},{"date":"2022-03-04","current":-6.489152,"twenty":-14.417826,"median":-10.04496,"eighty":-7.967497,"marketCap":34167224},{"date":"2022-03-11","current":-5.804446,"twenty":-14.284934,"median":-9.601456,"eighty":-7.799432,"marketCap":30562049},{"date":"2022-03-18","current":-6.037868,"twenty":-14.097087,"median":-9.53921,"eighty":-7.709175,"marketCap":31791086},{"date":"2022-03-25","current":-4.508748,"twenty":-13.912233,"median":-9.461402,"eighty":-7.587795,"marketCap":34768693},{"date":"2022-04-01","current":-4.305265,"twenty":-13.866632,"median":-9.352472,"eighty":-7.385496,"marketCap":33199559},{"date":"2022-04-08","current":-3.962557,"twenty":-13.819499,"median":-9.321349,"eighty":-7.074265,"marketCap":30556808},{"date":"2022-04-14","current":-3.673398,"twenty":-13.759797,"median":-9.259103,"eighty":-6.707014,"marketCap":28326987},{"date":"2022-04-22","current":-3.512753,"twenty":-13.737801,"median":-9.13461,"eighty":-6.426906,"marketCap":27088198},{"date":"2022-04-29","current":-3.137917,"twenty":-13.667521,"median":-8.870065,"eighty":-6.000521,"marketCap":24197689},{"date":"2022-05-06","current":-3.127207,"twenty":-13.528954,"median":-8.862284,"eighty":-5.707964,"marketCap":24115103},{"date":"2022-05-13","current":-1.95729,"twenty":-13.472398,"median":-8.82338,"eighty":-4.98591,"marketCap":20481320},{"date":"2022-05-20","current":-2.170383,"twenty":-13.37062,"median":-8.745572,"eighty":-4.429497,"marketCap":22711141},{"date":"2022-05-27","current":-1.878367,"twenty":-13.321969,"median":-8.698888,"eighty":-4.28813,"marketCap":19655460},{"date":"2022-06-03","current":-1.941506,"twenty":-13.254895,"median":-8.449903,"eighty":-4.144621,"marketCap":20316148},{"date":"2022-06-10","current":-2.099352,"twenty":-13.228761,"median":-8.411,"eighty":-3.951848,"marketCap":21967868},{"date":"2022-06-17","current":-1.531106,"twenty":-13.228761,"median":-8.356534,"eighty":-3.646624,"marketCap":16021678},{"date":"2022-06-24","current":-1.602137,"twenty":-13.040227,"median":-8.216481,"eighty":-3.547024,"marketCap":16764951},{"date":"2022-07-01","current":-2.47029,"twenty":-12.791992,"median":-8.138673,"eighty":-3.422793,"marketCap":25849408},{"date":"2022-07-08","current":-2.509751,"twenty":-12.647449,"median":-8.0064,"eighty":-3.315696,"marketCap":26262338},{"date":"2022-07-15","current":-2.628136,"twenty":-12.518618,"median":-7.936373,"eighty":-3.122923,"marketCap":27501128},{"date":"2022-07-22","current":-2.359798,"twenty":-12.4652,"median":-7.8041,"eighty":-2.596931,"marketCap":24693205},{"date":"2022-07-29","current":-2.241413,"twenty":-12.374076,"median":-7.734074,"eighty":-2.486075,"marketCap":23454415},{"date":"2022-08-05","current":-2.628136,"twenty":-12.308089,"median":-7.702951,"eighty":-2.475025,"marketCap":27501128},{"date":"2022-08-12","current":-1.791421,"twenty":-12.294129,"median":-7.625143,"eighty":-2.440299,"marketCap":24693205},{"date":"2022-08-19","current":-1.47987,"twenty":-12.277835,"median":-7.508432,"eighty":-2.381896,"marketCap":20398734},{"date":"2022-08-26","current":-1.473878,"twenty":-12.260956,"median":-7.329474,"eighty":-2.321915,"marketCap":20316148},{"date":"2022-09-02","current":-1.455904,"twenty":-12.245245,"median":-7.127175,"eighty":-2.214579,"marketCap":20068390},{"date":"2022-09-09","current":-1.677585,"twenty":-12.226391,"median":-6.932656,"eighty":-2.146706,"marketCap":23124071},{"date":"2022-09-16","current":-1.647628,"twenty":-12.169831,"median":-6.707014,"eighty":-2.086724,"marketCap":22711141},{"date":"2022-09-23","current":-1.401982,"twenty":-12.094418,"median":-6.496933,"eighty":-1.988588,"marketCap":19325116},{"date":"2022-09-30","current":-1.294137,"twenty":-12.034716,"median":-6.349099,"eighty":-1.949398,"marketCap":17838569},{"date":"2022-10-07","current":-1.210258,"twenty":-11.975013,"median":-6.014526,"eighty":-1.900466,"marketCap":16682365},{"date":"2022-10-14","current":-1.078448,"twenty":-11.918454,"median":-5.804446,"eighty":-1.846798,"marketCap":14865474},{"date":"2022-10-21","current":-1.096422,"twenty":-11.85561,"median":-5.687735,"eighty":-1.791473,"marketCap":15113232},{"date":"2022-10-28","current":-1.081383,"twenty":-11.726778,"median":-5.073054,"eighty":-1.753669,"marketCap":14905941},{"date":"2022-11-04","current":-1.108464,"twenty":-11.522533,"median":-4.487329,"eighty":-1.712991,"marketCap":15279230},{"date":"2022-11-11","current":-1.13338,"twenty":-11.465973,"median":-4.423071,"eighty":-1.656016,"marketCap":15735104},{"date":"2022-11-18","current":-1.07675,"twenty":-11.381133,"median":-4.305265,"eighty":-1.620928,"marketCap":14948886},{"date":"2022-11-25","current":-1.053253,"twenty":-11.296293,"median":-4.267781,"eighty":-1.602847,"marketCap":14622671},{"date":"2022-12-02","current":-1.112382,"twenty":-11.290009,"median":-4.144621,"eighty":-1.575732,"marketCap":15443576},{"date":"2022-12-09","current":-1.011256,"twenty":-11.255444,"median":-4.042879,"eighty":-1.546973,"marketCap":14039614},{"date":"2022-12-16","current":-1.088587,"twenty":-11.211453,"median":-3.769784,"eighty":-1.499042,"marketCap":15113232},{"date":"2022-12-23","current":-0.919778,"twenty":-11.170604,"median":-3.658405,"eighty":-1.473878,"marketCap":12769591},{"date":"2022-12-30","current":-0.87742,"twenty":-11.10776,"median":-3.603785,"eighty":-1.431939,"marketCap":12181518},{"date":"2023-01-06","current":-0.956145,"twenty":-10.624771,"median":-3.534172,"eighty":-1.399585,"marketCap":13274494},{"date":"2023-01-13","current":-0.986341,"twenty":-10.279938,"median":-3.480625,"eighty":-1.310913,"marketCap":13693706},{"date":"2023-01-20","current":-0.992392,"twenty":-10.009168,"median":-3.405657,"eighty":-1.294137,"marketCap":13777717},{"date":"2023-01-27","current":-1.010545,"twenty":-9.847328,"median":-3.314626,"eighty":-1.203068,"marketCap":14029748},{"date":"2023-02-03","current":-1.028699,"twenty":-9.694825,"median":-3.137917,"eighty":-1.161384,"marketCap":14281779},{"date":"2023-02-10","current":-1.022648,"twenty":-9.573445,"median":-2.875532,"eighty":-1.133,"marketCap":14197769},{"date":"2023-02-17","current":-1.072993,"twenty":-9.545434,"median":-2.628136,"eighty":-1.114432,"marketCap":14896736},{"date":"2023-02-24","current":-1.01345,"twenty":-9.53921,"median":-2.588674,"eighty":-1.108428,"marketCap":14070073},{"date":"2023-03-03","current":-1.040801,"twenty":-9.532985,"median":-2.497913,"eighty":-1.09529,"marketCap":14449800},{"date":"2023-03-10","current":-1.022164,"twenty":-9.49875,"median":-2.486075,"eighty":-1.090502,"marketCap":14191048},{"date":"2023-03-17","current":-0.950212,"twenty":-9.442728,"median":-2.47029,"eighty":-1.08326,"marketCap":13609696},{"date":"2023-03-24","current":-1.114446,"twenty":-9.396043,"median":-2.446613,"eighty":-1.079622,"marketCap":15961989},{"date":"2023-03-31","current":-1.085119,"twenty":-9.355584,"median":-2.41899,"eighty":-1.074981,"marketCap":15541936},{"date":"2023-04-06","current":-1.040424,"twenty":-9.33691,"median":-2.379529,"eighty":-1.073479,"marketCap":14901777},{"date":"2023-04-14","current":-1.067522,"twenty":-9.333798,"median":-2.359798,"eighty":-1.072482,"marketCap":15289905},{"date":"2023-04-21","current":-1.643515,"twenty":-9.315124,"median":-2.269036,"eighty":-1.072667,"marketCap":23539733},{"date":"2023-04-28","current":-1.566384,"twenty":-9.284001,"median":-2.217736,"eighty":-1.073019,"marketCap":22434996},{"date":"2023-05-05","current":-1.46057,"twenty":-9.259103,"median":-2.158545,"eighty":-1.073174,"marketCap":20919447},{"date":"2023-05-12","current":-1.143774,"twenty":-9.252878,"median":-2.115136,"eighty":-1.073479,"marketCap":16382041},{"date":"2023-05-19","current":-1.15382,"twenty":-9.190631,"median":-2.087514,"eighty":-1.074411,"marketCap":17550627},{"date":"2023-05-26","current":-1.005195,"twenty":-9.035016,"median":-2.020429,"eighty":-1.074411,"marketCap":15289905},{"date":"2023-06-02","current":-0.961011,"twenty":-9.010118,"median":-1.983145,"eighty":-1.072993,"marketCap":14617821},{"date":"2023-06-09","current":-1.159841,"twenty":-8.870065,"median":-1.953344,"eighty":-1.072456,"marketCap":17642198},{"date":"2023-06-16","current":-1.082518,"twenty":-8.870065,"median":-1.941506,"eighty":-1.072586,"marketCap":16466052},{"date":"2023-06-23","current":-1.04938,"twenty":-8.870065,"median":-1.933614,"eighty":-1.070994,"marketCap":15961989},{"date":"2023-06-30","current":-0.972057,"twenty":-8.860728,"median":-1.878367,"eighty":-1.064921,"marketCap":14785842},{"date":"2023-07-07","current":-1.060426,"twenty":-8.848278,"median":-1.846798,"eighty":-1.061657,"marketCap":16130010},{"date":"2023-07-14","current":-1.071472,"twenty":-8.832717,"median":-1.814213,"eighty":-1.061657,"marketCap":16298031},{"date":"2023-07-21","current":-1.060426,"twenty":-8.810931,"median":-1.791421,"eighty":-1.060426,"marketCap":16130010},{"date":"2023-07-28","current":-1.04938,"twenty":-8.773583,"median":-1.779441,"eighty":-1.055258,"marketCap":15961989},{"date":"2023-08-04","current":-0.966534,"twenty":-8.745572,"median":-1.744198,"eighty":-1.055258,"marketCap":14701832},{"date":"2023-08-11","current":-1.220594,"twenty":-8.739348,"median":-1.725516,"eighty":-1.052876,"marketCap":18566313},{"date":"2023-08-18","current":-1.373317,"twenty":-8.717562,"median":-1.677585,"eighty":-1.053044,"marketCap":20078502},{"date":"2023-08-25","current":-1.465254,"twenty":-8.680214,"median":-1.662443,"eighty":-1.053913,"marketCap":21422669},{"date":"2023-09-01","current":-1.654875,"twenty":-8.571283,"median":-1.65362,"eighty":-1.055258,"marketCap":24195015},{"date":"2023-09-08","current":-1.815766,"twenty":-8.446791,"median":-1.659611,"eighty":-1.056424,"marketCap":26547308},{"date":"2023-09-15","current":-1.81002,"twenty":-8.43123,"median":-1.67756,"eighty":-1.0591,"marketCap":26463298},{"date":"2023-09-22","current":-1.91345,"twenty":-8.415669,"median":-1.712629,"eighty":-1.05983,"marketCap":27975486},{"date":"2023-09-29","current":-1.580176,"twenty":-8.396994,"median":-1.67756,"eighty":-1.060426,"marketCap":23102879},{"date":"2023-10-06","current":-1.505477,"twenty":-8.368984,"median":-1.659611,"eighty":-1.060672,"marketCap":22010743},{"date":"2023-10-13","current":-1.44227,"twenty":-8.350309,"median":-1.65362,"eighty":-1.061657,"marketCap":21086627},{"date":"2023-10-20","current":-1.5457,"twenty":-8.303625,"median":-1.643515,"eighty":-1.061657,"marketCap":22598816},{"date":"2023-10-27","current":-1.223918,"twenty":-8.260053,"median":-1.625814,"eighty":-1.061657,"marketCap":17894230},{"date":"2023-11-03","current":-1.430778,"twenty":-8.216481,"median":-1.607859,"eighty":-1.063416,"marketCap":20918607},{"date":"2023-11-10","current":-1.278395,"twenty":-8.18847,"median":-1.602137,"eighty":-1.064711,"marketCap":19273682},{"date":"2023-11-17","current":-1.198043,"twenty":-8.132448,"median":-1.590231,"eighty":-1.064921,"marketCap":18062251},{"date":"2023-11-24","current":-1.170181,"twenty":-8.082652,"median":-1.580176,"eighty":-1.066012,"marketCap":17642198},{"date":"2023-12-01","current":-1.259338,"twenty":-8.014181,"median":-1.575732,"eighty":-1.06881,"marketCap":18986366},{"date":"2023-12-08","current":-1.225904,"twenty":-7.967497,"median":-1.562071,"eighty":-1.070868,"marketCap":18482303},{"date":"2023-12-15","current":-1.097741,"twenty":-7.955047,"median":-1.551766,"eighty":-1.070868,"marketCap":16550062},{"date":"2023-12-22","current":-1.036335,"twenty":-7.917699,"median":-1.544264,"eighty":-1.066012,"marketCap":15624267},{"date":"2023-12-29","current":-0.975151,"twenty":-7.889689,"median":-1.542628,"eighty":-1.064589,"marketCap":14701832},{"date":"2024-01-05","current":-0.99744,"twenty":-7.852341,"median":-1.531031,"eighty":-1.061657,"marketCap":15037874},{"date":"2024-01-12","current":-1.003012,"twenty":-7.799432,"median":-1.530311,"eighty":-1.059391,"marketCap":15121884},{"date":"2024-01-19","current":-0.972365,"twenty":-7.774534,"median":-1.51201,"eighty":-1.056545,"marketCap":14659827},{"date":"2024-01-26","current":-0.957988,"twenty":-7.752748,"median":-1.506456,"eighty":-1.052876,"marketCap":14443080},{"date":"2024-02-02","current":-0.952806,"twenty":-7.727849,"median":-1.499731,"eighty":-1.04938,"marketCap":14364950},{"date":"2024-02-09","current":-0.947289,"twenty":-7.712288,"median":-1.498787,"eighty":-1.048264,"marketCap":14281779},{"date":"2024-02-16","current":-0.961945,"twenty":-7.702951,"median":-1.493985,"eighty":-1.041288,"marketCap":14502727},{"date":"2024-02-23","current":-1.064308,"twenty":-7.690502,"median":-1.483973,"eighty":-1.040499,"marketCap":16045999},{"date":"2024-03-01","current":-1.225904,"twenty":-7.637593,"median":-1.475312,"eighty":-1.040499,"marketCap":18482303},{"date":"2024-03-08","current":-1.053163,"twenty":-7.612694,"median":-1.473878,"eighty":-1.040801,"marketCap":15877978},{"date":"2024-03-15","current":-1.057432,"twenty":-7.556672,"median":-1.471,"eighty":-1.041044,"marketCap":16309266},{"date":"2024-03-22","current":-1.256738,"twenty":-7.522437,"median":-1.466001,"eighty":-1.041044,"marketCap":19383264},{"date":"2024-03-28","current":-1.378537,"twenty":-7.485089,"median":-1.465254,"eighty":-1.042018,"marketCap":21261818},{"date":"2024-04-05","current":-1.245666,"twenty":-7.469528,"median":-1.454833,"eighty":-1.043021,"marketCap":19212486},{"date":"2024-04-12","current":-1.52248,"twenty":-7.329474,"median":-1.448839,"eighty":-1.043856,"marketCap":23481928},{"date":"2024-04-19","current":-1.395145,"twenty":-7.173859,"median":-1.451415,"eighty":-1.047591,"marketCap":21517985},{"date":"2024-04-26","current":-1.206911,"twenty":-7.142736,"median":-1.448016,"eighty":-1.049273,"marketCap":18614764},{"date":"2024-05-03","current":-1.110026,"twenty":-7.111613,"median":-1.444968,"eighty":-1.04938,"marketCap":17120460},{"date":"2024-05-10","current":-1.188735,"twenty":-7.049367,"median":-1.436524,"eighty":-1.04938,"marketCap":17803571},{"date":"2024-05-17","current":-1.368328,"twenty":-6.815944,"median":-1.432009,"eighty":-1.04938,"marketCap":20493319},{"date":"2024-05-24","current":-1.345522,"twenty":-6.707014,"median":-1.430778,"eighty":-1.04938,"marketCap":20151763},{"date":"2024-05-31","current":-1.413938,"twenty":-6.707014,"median":-1.427905,"eighty":-1.04938,"marketCap":21176429},{"date":"2024-06-07","current":-1.500542,"twenty":-6.545174,"median":-1.430778,"eighty":-1.04938,"marketCap":22473486},{"date":"2024-06-14","current":-1.391133,"twenty":-6.504714,"median":-1.429342,"eighty":-1.051467,"marketCap":20834874},{"date":"2024-06-21","current":-1.322717,"twenty":-6.498489,"median":-1.426468,"eighty":-1.052876,"marketCap":19810208},{"date":"2024-06-28","current":-1.299911,"twenty":-6.492264,"median":-1.422336,"eighty":-1.052895,"marketCap":19468653},{"date":"2024-07-05","current":-1.191585,"twenty":-6.442468,"median":-1.413952,"eighty":-1.053059,"marketCap":17846265},{"date":"2024-07-12","current":-1.265703,"twenty":-6.373997,"median":-1.413587,"eighty":-1.053217,"marketCap":18956320},{"date":"2024-07-15","current":-1.282807,"twenty":-6.361548,"median":-1.410912,"eighty":-1.053235,"marketCap":19212486},{"date":"2024-08-02","current":-1.16878,"twenty":-6.349099,"median":-1.408237,"eighty":-1.053253,"marketCap":17504710},{"date":"2024-08-09","current":-0.986393,"twenty":-6.271291,"median":-1.402259,"eighty":-1.052858,"marketCap":14773121},{"date":"2024-08-16","current":-1.081392,"twenty":-6.037868,"median":-1.396301,"eighty":-1.052904,"marketCap":17028796},{"date":"2024-08-23","current":-1.029588,"twenty":-5.991184,"median":-1.393111,"eighty":-1.04938,"marketCap":16213045},{"date":"2024-08-30","current":-1.074916,"twenty":-5.991184,"median":-1.389999,"eighty":-1.04938,"marketCap":16926827},{"date":"2024-09-06","current":-0.977785,"twenty":-5.841794,"median":-1.384008,"eighty":-1.04938,"marketCap":15397294},{"date":"2024-09-13","current":-0.990736,"twenty":-5.767098,"median":-1.379134,"eighty":-1.04873,"marketCap":15601232},{"date":"2024-09-20","current":-0.97131,"twenty":-5.707964,"median":-1.373317,"eighty":-1.041775,"marketCap":15295326},{"date":"2024-09-27","current":-0.686392,"twenty":-5.683066,"median":-1.365128,"eighty":-1.038333,"marketCap":10808697},{"date":"2024-10-04","current":-0.757622,"twenty":-5.393622,"median":-1.350855,"eighty":-1.035908,"marketCap":11930354},{"date":"2024-10-11","current":-0.73172,"twenty":-5.122851,"median":-1.344222,"eighty":-1.03475,"marketCap":11522478},{"date":"2024-10-18","current":-1.003687,"twenty":-4.98591,"median":-1.334119,"eighty":-1.032714,"marketCap":15805170},{"date":"2024-10-25","current":-0.964835,"twenty":-4.599823,"median":-1.327905,"eighty":-1.030617,"marketCap":15193357},{"date":"2024-10-31","current":-0.80295,"twenty":-4.483045,"median":-1.31871,"eighty":-1.028976,"marketCap":12644136},{"date":"2024-11-08","current":-0.770572,"twenty":-4.459483,"median":-1.312111,"eighty":-1.028699,"marketCap":12134291},{"date":"2024-11-15","current":-0.770221,"twenty":-4.435922,"median":-1.306342,"eighty":-1.022927,"marketCap":11471494},{"date":"2024-11-22","current":-0.71545,"twenty":-4.416645,"median":-1.301028,"eighty":-1.021764,"marketCap":10655743},{"date":"2024-11-29","current":-0.698334,"twenty":-4.369523,"median":-1.298344,"eighty":-1.019729,"marketCap":10400821},{"date":"2024-12-06","current":-0.657256,"twenty":-4.305265,"median":-1.294174,"eighty":-1.016645,"marketCap":9789008},{"date":"2024-12-13","current":-0.691488,"twenty":-4.296697,"median":-1.294137,"eighty":-1.016551,"marketCap":10298852},{"date":"2024-12-20","current":-0.609331,"twenty":-4.270994,"median":-1.28442,"eighty":-1.013136,"marketCap":9075226},{"date":"2024-12-27","current":-0.581945,"twenty":-4.247433,"median":-1.280601,"eighty":-1.010687,"marketCap":8667351},{"date":"2025-01-03","current":-0.585231,"twenty":-4.230298,"median":-1.272375,"eighty":-1.006355,"marketCap":8716296},{"date":"2025-01-10","current":-0.664102,"twenty":-4.161756,"median":-1.268003,"eighty":-1.003552,"marketCap":9890977},{"date":"2025-01-17","current":-0.575167,"twenty":-4.136053,"median":-1.261084,"eighty":-0.998976,"marketCap":8566402},{"date":"2025-01-24","current":-0.88189,"twenty":-4.127485,"median":-1.260002,"eighty":-0.99744,"marketCap":13134654},{"date":"2025-01-31","current":-0.886631,"twenty":-4.026815,"median":-1.257464,"eighty":-0.993446,"marketCap":13205270},{"date":"2025-02-07","current":-0.760417,"twenty":-3.956132,"median":-1.245666,"eighty":-0.988608,"marketCap":11325461},{"date":"2025-02-14","current":-0.742399,"twenty":-3.84261,"median":-1.238589,"eighty":-0.98707,"marketCap":11057119},{"date":"2025-02-21","current":-0.730167,"twenty":-3.73123,"median":-1.231675,"eighty":-0.985779,"marketCap":10874928},{"date":"2025-02-28","current":-0.745082,"twenty":-3.672113,"median":-1.225904,"eighty":-0.981039,"marketCap":11097073},{"date":"2025-03-07","current":-0.768098,"twenty":-3.660761,"median":-1.225849,"eighty":-0.980463,"marketCap":11439860},{"date":"2025-03-14","current":-0.75853,"twenty":-3.63163,"median":-1.220594,"eighty":-0.977669,"marketCap":11394665},{"date":"2025-03-21","current":-0.725399,"twenty":-3.604856,"median":-1.214046,"eighty":-0.975565,"marketCap":10896965},{"date":"2025-03-28","current":-0.62435,"twenty":-3.581295,"median":-1.208689,"eighty":-0.974516,"marketCap":9379008},{"date":"2025-04-04","current":-0.451645,"twenty":-3.538456,"median":-1.2078,"eighty":-0.972057,"marketCap":6784630},{"date":"2025-04-11","current":-0.461059,"twenty":-3.504185,"median":-1.201375,"eighty":-0.9697,"marketCap":6926037},{"date":"2025-04-17","current":-0.46394,"twenty":-3.489192,"median":-1.198043,"eighty":-0.966865,"marketCap":6969324},{"date":"2025-04-25","current":-0.476427,"twenty":-3.469915,"median":-1.196616,"eighty":-0.961198,"marketCap":7156905},{"date":"2025-05-02","current":-0.451453,"twenty":-3.422793,"median":-1.191585,"eighty":-0.952817,"marketCap":6781744},{"date":"2025-05-09","current":-0.409531,"twenty":-3.388522,"median":-1.187817,"eighty":-0.95007,"marketCap":6151980},{"date":"2025-05-16","current":-0.384834,"twenty":-3.31998,"median":-1.181326,"eighty":-0.947289,"marketCap":6060282},{"date":"2025-05-23","current":-0.386306,"twenty":-3.317838,"median":-1.173755,"eighty":-0.94295,"marketCap":6083468},{"date":"2025-05-30","current":-0.407281,"twenty":-3.309271,"median":-1.171024,"eighty":-0.938933,"marketCap":6413777},{"date":"2025-06-06","current":-0.353215,"twenty":-3.234303,"median":-1.170014,"eighty":-0.93188,"marketCap":5562348},{"date":"2025-06-13","current":-0.345273,"twenty":-3.137917,"median":-1.167696,"eighty":-0.925982,"marketCap":5437279}],"updateTime":1749937934992}}}